The TREAT PTSD TRICARE Act directs the Department of Defense to provide stellate ganglion block, a nerve block injection treatment, to military members and veterans diagnosed with post-traumatic stress disorder who are enrolled in TRICARE health coverage. The treatment would be available to anyone in the active-duty or reserve components who has elected to receive it after being informed of the risks and benefits by a qualified healthcare provider. The bill requires the Secretary of Defense to update military clinical practice guidelines within 180 days to include stellate ganglion block as a therapy option for PTSD and to notify Congress of these changes. The provision becomes effective 180 days after the bill is enacted. No specific funding amount is allocated in the legislation, though the Department may provide the procedure either through its own medical facilities or through contracted TRICARE providers.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.